The hallucinatory drug PCP (phencyclidine)
a. is an antagonist of the NMDA receptor.
b. facilitates the binding of glutamate to the AMPA receptor.
c. releases serotonin from neurons in the raphe nuclei.
d. inhibits the dendrites of dopamine neurons in the ventral tegmental area.
e. acts via the blockade of serotonin receptors.
Question 2
Which of the following is true of NMDA receptors?
a. Activation of the NMDA receptor allows sodium and calcium ions to flow into the nerve cell.
b. NMDA receptors are metabotropic.
c. NMDA receptors are the most common glutamate receptor.
d. The activity of the NMDA receptor is not dependent on magnesium ions.
e. The NMDA receptor produces IPSPs.
Multiple-dose drug administration: drug A and drug B are administered every 12 hours; drug B reaches
Drug Actions at Binding Sites
Nursing Responsibilities Related to Adverse Drug Reactions and Drug Interactions in Older Adults
The basic structure of the IL-2 receptor.
First-pass metabolism (biotransformation). Absorption of an orally administered drug.
Structure of the human b2-adrenergic receptor